Non-specific lipid-transfer Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (12-14 weeks)
Synonyms
Non-specific lipid-transfer protein (LTP) (NsLTP) (SDI-9)
Target Names
Non-specific lipid-transfer protein
Uniprot No.

Target Background

Function
Plant non-specific lipid-transfer proteins facilitate the movement of phospholipids and galactolipids across membranes. These proteins are thought to play a crucial role in the deposition of wax or cutin within the cell walls of expanding epidermal cells and certain secretory tissues.
Database Links

UniGene: Han.1167

Protein Families
Plant LTP family

Q&A

What are non-specific lipid transfer proteins and why are they important research targets?

Non-specific lipid transfer proteins (nsLTPs) are plant-specific cysteine-rich antimicrobial peptides characterized by their small size (6.5-10.5 kDa) and the presence of eight cysteine residues forming four disulfide bonds . They received this name due to their ability to bind various hydrophobic molecules, including phospholipids and fatty acids . nsLTPs are significant research targets because they play multifaceted roles in plant molecular physiology, development, and defense mechanisms against pathogens . Additionally, they represent major allergens in various plant foods and pollens, with potential applications as biotherapeutic agents in antimicrobial drug development .

What is the basic structure of nsLTPs that antibodies typically recognize?

nsLTPs typically have a conserved structure consisting of 91-93 amino acids (approximately 9 kDa) with high isoelectric points . The most distinctive structural feature recognized by antibodies is the conserved 8-cysteine motif (8CM domain) that forms four disulfide bridges . These disulfide bridges contribute to the folding of nsLTPs into a compact, three-dimensional structure characterized by high thermal and proteolytic stability . This unique structure creates specific epitopes that antibodies recognize, particularly in the case of Pru p 3 (peach nsLTP), which contains four major immunodominant IgE epitopes shared by LTPs of fruits from the Rosaceae family .

How do researchers distinguish between different types of nsLTPs when developing antibodies?

Researchers distinguish between different nsLTP types through a combination of molecular and immunological techniques. Initially, SDS-PAGE and mass spectrometry (MALDI-TOF) are used to identify the specific nsLTP based on molecular weight and sequence characteristics . For antibody development, researchers must carefully consider the conserved regions versus variable regions across nsLTP family members. For example, studies have shown that Pru p 3 from peach contains immunodominant epitopes not present in more distantly related nsLTPs like Cor a 8 in hazelnut . Therefore, epitope mapping is essential to develop antibodies that can either recognize specific nsLTPs or detect shared epitopes across multiple nsLTPs. Sequence alignment and structural analysis help identify unique regions for generating antibodies with high specificity to target particular nsLTP family members.

What are the optimal methods for isolating and purifying nsLTPs for antibody development?

The optimal isolation and purification of nsLTPs typically involves a multi-step process:

  • Initial extraction from plant material using appropriate buffers

  • Fractionation using gel filtration chromatography to separate proteins by size

  • Further purification through reverse-phase high-performance liquid chromatography (RP-HPLC)

  • Verification of purity and identity using:

    • Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)

    • Mass spectrometry (MALDI-TOF)

This approach ensures high purity of the nsLTP proteins, which is essential for generating specific antibodies. For recombinant nsLTPs, researchers can use expression systems (typically bacterial) followed by affinity chromatography and additional purification steps to obtain protein for immunization. The purification protocol may need optimization based on the specific properties of the nsLTP being studied, including its isoelectric point and hydrophobicity.

How can researchers validate the specificity of anti-nsLTP antibodies?

Validation of anti-nsLTP antibodies requires multiple approaches to ensure specificity:

  • Western blotting against purified nsLTPs and plant extracts to confirm antibody binding to the target protein at the expected molecular weight

  • ELISA assays to quantify binding affinity and detect potential cross-reactivity with related nsLTPs

  • Immunolocalization studies to confirm that antibodies detect nsLTPs in their expected cellular locations

  • Pre-absorption controls using purified nsLTPs to demonstrate binding specificity

  • Testing against nsLTPs from multiple plant species to assess cross-reactivity patterns

  • Competitive binding assays to compare antibody affinity for different nsLTP variants

Researchers should particularly focus on testing against closely related nsLTPs to ensure the antibody can discriminate between family members when specificity is required. For example, when developing antibodies against TdLTP2, validation should include testing against other LTP family members to confirm specificity .

What experimental controls are essential when using anti-nsLTP antibodies in immunoassays?

When using anti-nsLTP antibodies in immunoassays, the following controls are essential:

  • Positive controls:

    • Purified recombinant or native nsLTP protein to confirm antibody reactivity

    • Plant extracts known to contain the target nsLTP

  • Negative controls:

    • Samples from plants/tissues not expressing the target nsLTP

    • Pre-immune serum (for polyclonal antibodies) or isotype controls (for monoclonal antibodies)

    • Antibody pre-absorbed with purified nsLTP to demonstrate binding specificity

  • Cross-reactivity controls:

    • Testing against related nsLTPs to assess specificity

    • Testing with plant extracts from different species to evaluate potential cross-reactivity

  • Technical controls:

    • Secondary antibody-only controls to detect non-specific binding

    • Blocking optimization to minimize background signal

These controls help ensure that any signals detected in immunoassays represent genuine nsLTP detection rather than experimental artifacts or cross-reactivity . For instance, when conducting fluor-immunolocalization studies with TdLTP2, appropriate controls would verify that the observed localization patterns are specific to the nsLTP of interest .

How can antibodies be used to study the lipid-binding properties of nsLTPs?

Antibodies can serve as valuable tools for studying nsLTP-lipid interactions through several methodological approaches:

  • Hydrophobic ELISA-based assays:

    • Coating hydrophobic plates with various lipids (oleic, linoleic, palmitic, stearic acids, etc.)

    • Incubating with nsLTPs at different concentrations

    • Detecting bound nsLTPs using specific antibodies

    • Calculating binding constants (Kd) for different lipid-nsLTP interactions

  • Competitive binding assays:

    • Using fluorescently labeled lipids and measuring displacement by unlabeled lipids

    • Detecting nsLTP-lipid complexes using specific antibodies

  • Co-immunoprecipitation studies:

    • Using anti-nsLTP antibodies to precipitate nsLTP-lipid complexes

    • Analyzing bound lipids using mass spectrometry or thin-layer chromatography (TLC)

  • Confirmation with molecular docking:

    • Validating experimental findings through in silico molecular docking studies

These methods provide insights into the lipid-binding specificity of different nsLTPs, which is crucial for understanding their biological functions and allergenicity. For example, research has shown that lipid binding can alter the allergenic properties of nsLTPs by modifying their structure or stability .

What strategies can researchers employ to develop antibodies that distinguish between different nsLTP conformational states?

Developing antibodies that distinguish between different nsLTP conformational states requires sophisticated strategies:

  • Strategic immunogen design:

    • Using native folded nsLTPs for antibodies recognizing natural conformations

    • Creating lipid-bound nsLTP complexes to generate antibodies specific to lipid-induced conformations

    • Utilizing heat-treated nsLTPs for antibodies recognizing denatured forms

  • Conformation-specific screening:

    • ELISA-based screening comparing antibody binding to different nsLTP states

    • Selecting clones that discriminate between lipid-bound and unbound states

    • Screening against nsLTPs in different pH conditions to detect pH-dependent conformational changes

  • Epitope mapping techniques:

    • Hydrogen-deuterium exchange mass spectrometry to identify conformation-dependent epitopes

    • Phage display with peptide libraries to identify short peptide epitopes

    • X-ray crystallography of antibody-nsLTP complexes to determine binding sites

  • Validation using biophysical methods:

    • Circular dichroism (CD) spectroscopy to confirm conformational changes

    • Surface plasmon resonance to measure binding kinetics to different conformational states

These approaches help develop antibodies that can serve as research tools to study how nsLTP conformational changes affect their biological activities, including their role as allergens and in plant defense mechanisms .

How can anti-nsLTP antibodies aid in understanding the immunological mechanisms behind nsLTP-mediated allergic reactions?

Anti-nsLTP antibodies provide crucial tools for investigating the immunological mechanisms of nsLTP-mediated allergies:

  • Epitope mapping:

    • Using monoclonal antibodies competing with patient IgE to identify allergenic epitopes

    • Comparing epitope recognition patterns across different patient populations

    • Identifying the four major immunodominant IgE epitopes of Pru p 3 that are shared with other Rosaceae LTPs

  • T-cell epitope studies:

    • Using antibodies to isolate nsLTP-peptide fragments presented by antigen-presenting cells

    • Characterizing Th2-dominated responses to immunodominant T-cell-activating regions of Pru p 3

  • Cross-reactivity analysis:

    • Employing antibody inhibition assays to assess cross-reactivity between different nsLTPs

    • Explaining why some nsLTPs like Pru p 3 are primary sensitizers while others (e.g., Cor a 8) demonstrate cross-reactivity

  • Adjuvant mechanism studies:

    • Investigating how nsLTP-lipid complexes promote sensitization via CD1d-mediated activation of invariant natural killer T-cells (iNKTs)

    • Using antibodies to track the processing and presentation of nsLTPs by dendritic cells

These approaches help researchers understand why nsLTPs are highly allergenic and how sensitization occurs, potentially leading to better diagnostic and therapeutic strategies for nsLTP-related allergies .

What experimental design is recommended for studying nsLTP expression patterns under different stress conditions?

A comprehensive experimental design for studying nsLTP expression should include:

  • Stress treatment setup:

    • Controlled application of various stressors (abiotic: drought, heat, salinity; biotic: pathogen infection)

    • Treatment with stress-related hormones (ABA, ethylene, methyl jasmonic acid, salicylic acid)

    • Time-course sampling to capture dynamic expression changes

  • Expression analysis methods:

    • qRT-PCR for transcript-level analysis

    • Western blotting with anti-nsLTP antibodies for protein-level detection

    • Immunohistochemistry to determine tissue and cellular localization changes

  • Functional validation:

    • RNA interference or CRISPR-based gene knockdown/knockout

    • Overexpression studies to confirm stress response functions

    • Correlation of nsLTP levels with stress resistance phenotypes

  • Data analysis considerations:

    • Multiple biological and technical replicates

    • Appropriate statistical methods for time-course data

    • Correlation analysis between nsLTP expression and physiological parameters

This experimental design allows researchers to comprehensively characterize how nsLTP expression responds to various stressors, providing insights into their roles in plant defense and stress adaptation .

How should researchers design experiments to study the structural stability of nsLTPs under different conditions?

An effective experimental design for studying nsLTP structural stability should include:

  • Stability assessment methods:

    • Circular dichroism (CD) spectroscopy to monitor secondary structure changes

    • Differential scanning calorimetry to determine thermal transition points

    • Limited proteolysis followed by mass spectrometry to identify stable domains

    • Analysis under various pH conditions to evaluate pH-dependent stability

  • Processing condition variables:

    • Heat treatment at different temperatures and durations

    • Exposure to gastric and intestinal digestive enzymes

    • pH variations from acidic to neutral conditions

    • Processing methods (boiling, roasting, high pressure)

  • Structural analysis techniques:

    • Monitoring disulfide bond integrity under different conditions

    • Comparing stability of different nsLTPs (e.g., Pru p 3 vs. Cor a 8)

    • Assessing the impact of bound lipids on structural stability

  • Functional correlations:

    • Measuring IgE binding capacity after various treatments

    • Correlating structural changes with allergenicity

    • Assessing how processing affects T-cell epitope presentation

This experimental design provides insights into why nsLTPs are particularly stable allergens that can retain their allergenicity even after processing, which is crucial information for understanding food allergy risks .

What approaches are recommended for developing a high-sensitivity detection system for nsLTPs using antibodies?

Developing a high-sensitivity nsLTP detection system requires careful consideration of several factors:

  • Antibody development strategy:

    • Generating high-affinity monoclonal antibodies targeting conserved regions

    • Producing detection and capture antibody pairs recognizing different epitopes

    • Validating antibody performance across various sample matrices

  • Assay format selection:

    • Sandwich ELISA for maximum sensitivity and specificity

    • Lateral flow immunoassays for rapid detection

    • Immunochromatographic methods for field applications

    • Advanced techniques like surface plasmon resonance for real-time kinetics

  • Signal amplification methods:

    • Enzyme-conjugated secondary antibodies with chemiluminescent substrates

    • Polymer-based signal enhancement systems

    • Quantum dot or gold nanoparticle conjugates for increased sensitivity

    • PCR-coupled immunoassays for ultra-high sensitivity

  • Validation protocol:

    • Determining limits of detection and quantification

    • Assessing specificity against related proteins

    • Testing with complex food or plant matrices

    • Comparing performance against established detection methods

This comprehensive approach ensures the development of antibody-based detection systems that can reliably detect nsLTPs in various sample types, which is essential for allergen detection in foods and for research applications .

How can researchers address the challenge of distinguishing between genuine sensitization and cross-reactivity in nsLTP allergy studies?

Addressing the challenge of distinguishing genuine sensitization from cross-reactivity requires sophisticated methodological approaches:

  • Molecular-based diagnostic strategies:

    • Component-resolved diagnostics using purified recombinant nsLTPs

    • IgE inhibition assays to determine primary sensitizing allergens

    • Comparison of binding affinities to different nsLTPs

  • Epitope analysis techniques:

    • Identification of immunodominant IgE epitopes using epitope mapping

    • Analysis of T-cell epitopes to detect primary sensitizing nsLTPs

    • Comparing epitope conservation across different nsLTPs

  • Clinical correlation studies:

    • Correlating molecular sensitization patterns with clinical symptoms

    • Distinguishing between asymptomatic sensitization and clinical allergy

    • Evaluating the correlation between IgE levels and symptom severity

  • Advanced analytical approaches:

    • Basophil activation tests to assess functional relevance of detected IgE

    • T-cell proliferation assays to identify primary sensitizers

    • Analysis of cross-reactive carbohydrate determinants to rule out clinically irrelevant cross-reactivity

These methodologies help researchers understand why some nsLTP-sensitized individuals develop clinical symptoms while others remain asymptomatic, and why certain nsLTPs (like Pru p 3) appear to be primary sensitizers while others primarily show cross-reactivity .

What methodological approaches can resolve contradictory data regarding nsLTP stability in different experimental conditions?

Resolving contradictory data regarding nsLTP stability requires systematic methodological approaches:

  • Standardized experimental protocols:

    • Establishing consistent pH, temperature, and time parameters

    • Using defined protein concentrations and buffer compositions

    • Ensuring comparable digestion conditions across studies

  • Comprehensive stability analysis:

    • Combining multiple analytical techniques (CD spectroscopy, DSC, NMR)

    • Monitoring both structural integrity and functional activity

    • Comparing results from in vitro and in vivo digestion models

  • Comparison of different nsLTPs under identical conditions:

    • Analyzing multiple nsLTPs (e.g., Pru p 3, Cor a 8) simultaneously

    • Investigating the impact of specific structural features on stability

    • Evaluating the influence of bound lipids on stability profiles

  • Context-dependent stability assessment:

    • Analyzing stability in food matrices versus purified systems

    • Evaluating the impact of processing methods on different nsLTPs

    • Considering the influence of the digestive environment (enzymes, bile salts)

These approaches help reconcile conflicting data, such as the observation that nsLTPs show high stability in acidic environments but reduced stability at neutral pH and high temperatures . Understanding these nuances is crucial for predicting allergenicity after food processing.

How can researchers develop a comprehensive panel of antibodies to study the complex cross-reactivity patterns among different nsLTPs?

Developing a comprehensive antibody panel for studying nsLTP cross-reactivity requires a strategic approach:

  • Strategic immunogen selection:

    • Using phylogenetically diverse nsLTPs as immunogens

    • Designing synthetic peptides representing unique and shared epitopes

    • Creating chimeric nsLTPs containing epitopes from multiple family members

  • Screening strategy development:

    • High-throughput screening against panels of purified nsLTPs

    • Selection of antibodies with defined cross-reactivity profiles

    • Epitope binning to identify antibodies recognizing distinct regions

  • Characterization of antibody specificities:

    • Detailed epitope mapping using peptide arrays or hydrogen-deuterium exchange

    • Competition binding assays to define overlapping epitopes

    • Structural analysis of antibody-antigen complexes

  • Validation with clinical samples:

    • Testing antibody inhibition of patient IgE binding

    • Correlation of antibody binding patterns with clinical cross-reactivity

    • Comparison with patient sensitization profiles

This approach helps develop antibody panels that can map the complex cross-reactivity patterns observed among nsLTPs from different plant species, providing insights into the structural basis of cross-reactivity and potentially identifying clinically relevant cross-reactive epitopes .

How might advanced structural biology techniques enhance our understanding of nsLTP-antibody interactions?

Advanced structural biology techniques offer promising avenues for deeper insights into nsLTP-antibody interactions:

  • Cryo-electron microscopy (cryo-EM):

    • Visualizing nsLTP-antibody complexes at near-atomic resolution

    • Capturing different conformational states without crystallization

    • Revealing structural dynamics of recognition and binding

  • X-ray crystallography of antibody-nsLTP complexes:

    • Determining precise atomic interactions at binding interfaces

    • Comparing epitope recognition across different nsLTPs

    • Understanding the structural basis of cross-reactivity

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

    • Mapping conformational changes upon antibody binding

    • Identifying regions of nsLTPs with altered solvent accessibility

    • Detecting allosteric effects of antibody binding

  • Single-particle FRET analysis:

    • Measuring dynamic interactions between nsLTPs and antibodies

    • Detecting conformational changes in real-time

    • Correlating structural dynamics with binding affinity

These techniques will provide unprecedented insights into the molecular details of nsLTP-antibody interactions, which could inform the development of diagnostic tools and therapeutic strategies for nsLTP-related allergies .

What methodological approaches can address the challenge of studying lipid-nsLTP-antibody complexes?

Studying the complex interactions between lipids, nsLTPs, and antibodies requires specialized methodological approaches:

  • Advanced lipid-protein complex isolation:

    • Nanodisc technology to stabilize lipid-nsLTP complexes

    • Native mass spectrometry to preserve and analyze intact complexes

    • Size-exclusion chromatography coupled with multi-angle light scattering

  • Structural characterization techniques:

    • Small-angle X-ray scattering (SAXS) to determine complex shapes

    • Solid-state NMR to analyze lipid-protein interactions

    • Cryo-EM to visualize lipid-bound conformations

  • Antibody interaction studies:

    • Surface plasmon resonance comparing antibody binding to free vs. lipid-bound nsLTPs

    • Epitope accessibility analysis in the presence of different lipids

    • Competitive binding assays between lipids and antibodies

  • Functional correlation approaches:

    • Investigating how lipid binding affects antibody recognition

    • Studying how antibody binding impacts lipid transfer activity

    • Determining how lipid-nsLTP complexes modulate immune responses

These approaches help researchers understand the critical role of lipid binding in nsLTP allergenicity, including how lipids may act as adjuvants to promote sensitization and how they might alter epitope recognition by antibodies.

How can single-cell analysis techniques advance our understanding of nsLTP-specific immune responses?

Single-cell analysis techniques offer powerful new approaches to understanding nsLTP-specific immune responses:

  • Single-cell RNA sequencing (scRNA-seq):

    • Characterizing heterogeneity in T-cell responses to nsLTPs

    • Identifying transcriptional signatures of nsLTP-reactive immune cells

    • Tracking clonal expansion of nsLTP-specific lymphocytes

  • Mass cytometry (CyTOF):

    • Profiling protein expression in nsLTP-responding cells

    • Mapping signaling pathways activated during allergic responses

    • Quantifying rare cell populations involved in sensitization

  • Single-cell protein secretion assays:

    • Measuring cytokine production by individual nsLTP-reactive cells

    • Correlating cytokine profiles with clinical phenotypes

    • Identifying key mediators of allergic inflammation

  • Advanced imaging techniques:

    • Multiplex immunofluorescence imaging of tissue samples

    • Spatial transcriptomics to map cell interactions during allergic responses

    • Intravital microscopy to visualize cellular dynamics in vivo

These techniques will revolutionize our understanding of the cellular basis of nsLTP allergy, potentially identifying biomarkers for disease severity, predicting cross-reactivity patterns, and developing personalized therapeutic approaches .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.